TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Investor Investigation over potential Wrongdoing

  • If you purchased shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), you have certain options and you should contact the Shareholders Foundation, inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Synergy Pharmaceuticals Inc
Security
NASDAQ: SGYP

Summary

April 13, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) was announced over potential breaches of fiduciary duties by certain officers and directors at Synergy Pharmaceuticals.

The investigation by a law firm concerns whether certain Synergy Pharmaceuticals Inc officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
New York based Synergy Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. Synergy Pharmaceuticals Inc reported that its Net Loss increased from $117.50 million in 2015 to $198.61 million in 2016.

Shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) declined from $6.73 per share in Janaury 2017 to as low as $3.98 per share on April 6, 2017.

On April 13, 2017, NASDAQ:SGYP shares closed at $4.55 per share.

Start Monitoring Your Investments